Mrs. Jill Renee Sheridan, SLP CCC S Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3040 Preakness Ct, Raceland, KY 41169 Phone: 606-388-4268 |
News Archive
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, announced today that it has completed the spin-out of Onset Therapeutics, LLC, its wholly owned subsidiary focused on the Dermatology market.
Aternity Inc., the industry's technology leader in end user experience management solutions for Global 1000 enterprises, announced today that Centene Corporation, a Fortune 500 company and leading multi-line healthcare enterprise that provides programs and related services to the rising number of under-insured and uninsured individuals, has selected the Aternity Frontline Performance Intelligence (FPI) Platform for its strategic end user experience management initiatives.
IBS remains a common intestinal disorder causing significant discomfort and poor quality of life in patients who have the diagnosis. TCAs have been shown to improve abdominal pain in patients with IBS; however, there is insufficient evidence of global symptom relief. The search for an optimal treatment to improve symptoms and quality of life in IBS remains ongoing.
The increased cost of drug development has impelled pharmaceutical companies to seek better opportunities in emerging markets to successfully expand and sell their products. Most pharmaceutical companies consider emerging markets lucrative due to their economical infrastructure and manpower costs and a significant untapped market potential with a large population.
A team led by University of Saskatchewan (USask) researcher Khan Wahid has been awarded $250,000 from the federal New Frontiers in Research Fund to create a new pill-sized capsule that uses artificial intelligence (AI)-enabled sensing to diagnose gastrointestinal cancers and bleeding earlier and more precisely than is currently possible.
› Verified 1 days ago